A scent booster composition having a pastille formulation and optionally a sodium chloride system. The pastille formulation contains by weight of the formulation (i) 1 to 30% of a fragrance microcapsule that has a microcapsule core and a microcapsule wall encapsulating the microcapsule core, in which the microcapsule core contains a fragrance, (ii) 0 to 40% of a free fragrance, (iii) 0 to 25% of a clay, and (iv) 50 to 70% of polyethylene glycol that has a molecular weight of 2,000 to 10,000. Also disclosed is a method of using the scent booster composition.

Nano- to microscale liquid coacervate particles are provided. The liquid coacervate particles are produced by a process including stimulating a population of liquid droplets containing one or a mixture of components to induce a phase separation point of a first component, and maintaining stimulation at the phase separation point to form a coacervate domain of the first component within each of the droplets to form the liquid coacervate particles. The self-assembled nano, meso, micro and macro liquid coacervate particles and related coated substrates can have utility in drug delivery, bioanalytical systems, controlled cell culture, tissue engineering, biomanufacturing and drug discovery.

Nano- to microscale liquid coacervate particles are provided. The liquid coacervate particles are produced by a process including stimulating a population of liquid droplets containing one or a mixture of components to induce a phase separation point of a first component, and maintaining stimulation at the phase separation point to form a coacervate domain of the first component within each of the droplets to form the liquid coacervate particles. The self-assembled nano, meso, micro and macro liquid coacervate particles and related coated substrates can have utility in drug delivery, bioanalytical systems, controlled cell culture, tissue engineering, biomanufacturing and drug discovery.

A nanocomposite for detection and treatment of a target of interest including tumor cells or pathogens includes at least one nanostructure, each nanostructure having a core and a shell surrounding the core; a reporter assembled on the shell of each nanostructure; and a layer of a treating agent and a targeting agent conjugated to the reporter. In use, the nanocomposite targets to the target of interest according to the targeting agent and releases the treating agent and the nanostructure therein for therapeutic treatment of the target of interest, and the target of interest transmits at least one signature responsive to the reporter for detection of the target of interest.

A package structure having a solder mask layer with a low dielectric constant includes a substrate, a conductive structure on the substrate, and a solder mask layer on the substrate. The solder mask layer includes bubbles and a solder mask material, wherein the bubbles are disposed within the solder mask layer and the solder mask material covers the bubbles.

Provided are a core-shell structured perovskite particle light-emitter, a method of preparing the same, and a light emitting device using the same. The core-shell structured perovskite particle light-emitter or metal halide perovskite particle light-emitter has a perovskite nanocrystal structure and a core-shell structured particle structure. Therefore, in the perovskite particle light-emitter of the present invention, as a shell is formed of a substance having a wider band gap than that of a core, excitons may be more dominantly confined in the core, and durability of the nanocrystal may be improved to prevent exposure of the core perovskite to the air using a perovskite or inorganic semiconductor, which is stable in the air, or a polymer.

Provided are a core-shell structured perovskite particle light-emitter, a method of preparing the same, and a light emitting device using the same. The core-shell structured perovskite particle light-emitter or metal halide perovskite particle light-emitter has a perovskite nanocrystal structure and a core-shell structured particle structure. Therefore, in the perovskite particle light-emitter of the present invention, as a shell is formed of a substance having a wider band gap than that of a core, excitons may be more dominantly confined in the core, and durability of the nanocrystal may be improved to prevent exposure of the core perovskite to the air using a perovskite or inorganic semiconductor, which is stable in the air, or a polymer.

The present invention relates to a core-shell capsule comprising: a core comprising an oil, a solvent satisfying relational expression 1 below, and a water-insoluble polymer compound dissolved in the solvent; and a water-insoluble polymer shell enclosing the core.
0.01≤C.sub.A/C.sub.B≤100  [Relational expression 1]
(in relational expression 1, C.sub.A/C.sub.B is the distribution coefficient of solvent, and when the solvent is dissolved in oil and water to reach equilibrium, C.sub.A is the concentration of the solvent dissolved in the oil and C.sub.B is the concentration of the solvent dissolved in water).

The present invention relates to a core-shell capsule comprising: a core comprising an oil, a solvent satisfying relational expression 1 below, and a water-insoluble polymer compound dissolved in the solvent; and a water-insoluble polymer shell enclosing the core.
0.01≤C.sub.A/C.sub.B≤100  [Relational expression 1]
(in relational expression 1, C.sub.A/C.sub.B is the distribution coefficient of solvent, and when the solvent is dissolved in oil and water to reach equilibrium, C.sub.A is the concentration of the solvent dissolved in the oil and C.sub.B is the concentration of the solvent dissolved in water).

Impermeable porous particles include a porous polymer core, and a polymeric shell having a shell thickness of at least 5 nm. The impermeable porous particles have a median diameter of between 3 μm and 200 μm, and any pores in the polymeric shell have a diameter of less than 2 nm.